Pharmaceutical News

RSS

Inhalable ibuprofen holds potential to treat cystic fibrosis

Ibuprofen: You can buy it at any drug store, and it will help with that stabbing headache or sprained ankle. One of the ways it does so is by reducing inflammation, and it is this property that may also help patients with cystic fibrosis.

4 Jul 2016

New supplement could help reduce urge to consume high-calorie foods

Eating a type of powdered food supplement, based on a molecule produced by bacteria in the gut, reduces cravings for high-calorie foods such as chocolate, cake and pizza, a new study suggests.

1 Jul 2016

Paracetamol use during pregnancy linked to hyperactivity, autism spectrum symptoms in children

A new study has found that paracetamol (acetaminophen), which is used extensively during pregnancy, has a strong association with autism spectrum symptoms in boys and for both genders in relation to attention-related and hyperactivity symptoms.

1 Jul 2016

Targeted molecular therapy reduces initial development of NAFLD in mice

Researchers report in the journal Cell Reports a targeted molecular therapy that dramatically reduces the initial development of Non Alcoholic Fatty Liver Disease (NAFLD) in laboratory mouse models of the disease.

1 Jul 2016

Researchers test experimental Zika virus vaccine in mice

An experimental vaccine against Zika virus developed by Brazilian and US researchers has been tested successfully in trials with mice.

30 Jun 2016

New study may help develop effective medication for severe pain

The nerve cells that transmit pain signals in the body are called nociceptors. When activated they release pro-inflammatory neuropeptides. In order to recognise harmful external influences, nociceptors are equipped with a wide range of receptors.

30 Jun 2016

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study by Mayo Clinic researchers published in the Lancet Haematology.

30 Jun 2016

Allergy-causing immune cells play life-saving role in deadly C. difficile infection

Researchers at the University of Virginia School of Medicine have identified immune cells vital for protecting us from potentially fatal C. difficile infection. Surprisingly, those cells are often vilified for their role in causing asthma and allergies. But when it comes to C. difficile, they could be the difference in life and death.

29 Jun 2016

Researcher receives federal grant to advance study of tumor nanoimmunology

The five-year grant was awarded by the National Cancer Institute of the National Institutes of Health. The funds come on top of four previous grants to support Ljubimova's work. In all, the institute has awarded Ljubimova $16.5 million over the last five years.

29 Jun 2016

Programs to prevent prescription drug misuse may be underused, study reveals

Misuse of prescription pain medications remains a major public health problem -- but programs to prevent it may be underused, according to a study in the July issue of the Journal of Studies on Alcohol and Drugs.

29 Jun 2016

Tiny doses of anti-HIV drug may be effective for treating Alzheimer's disease

For a promising pathway to treating Alzheimer's patients, "aim here." That's what National Institute of Standards of Technology researchers advised collaborators hunting for molecules that, by linking to a normally occurring enzyme, rev up the brain's capacity for clearing cholesterol--a boost associated with improvements in memory and other benefits in animal studies.

29 Jun 2016

Bioengineers develop 2-in-1 nanomedicine for treating cancer

For cancer therapy, treatment resistance poses a major hurdle. Even aggressive treatments such as immunotherapies or nanomedicines may fail to eliminate all cancer cells, allowing new mutations to develop that may cause relapse.

28 Jun 2016

Experimental lipid-lowering drug improves glucose control in diabetic patients

High triglycerides -- a type of fat, or lipid, in the blood -- increase the risk of heart disease and perhaps type 2 diabetes. For the first time, it has been shown that profoundly lowering triglycerides in diabetics improves their insulin sensitivity over time, which helps them maintain healthy glucose - blood sugar -- levels.

28 Jun 2016

Blocking c-Abl enzyme prevents Parkinson’s disease progression in mice

Researchers at Johns Hopkins say they have gleaned two important new clues in the fight against Parkinson's disease: that blocking an enzyme called c-Abl prevents the disease in specially bred mice, and that a chemical tag on a second protein may signal the disorder's presence and progression.

28 Jun 2016

Researchers test new drug with potential to reverse or slow progression of asthma

A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.

28 Jun 2016

Pain reliever appears to help preserve vision in animal model of retinal degeneration

A pain medicine that potently activates a receptor vital to a healthy retina appears to help preserve vision in a model of severe retinal degeneration, scientists report.

28 Jun 2016

Cisplatin-based chemotherapy may lead to hearing loss in many testicular cancer survivors

Many testicular cancer survivors experience hearing loss after cisplatin-based chemotherapy, according to researchers at Indiana University.

28 Jun 2016

Anti-anxiety medication dampens helping behavior in rats

Rats given midazolam, an anti-anxiety medication, were less likely to free trapped companions because the drug lessened their empathy, according to a new study by University of Chicago neuroscientists.

28 Jun 2016

Anthrax capsule vaccine offers protection from deadly anthrax infection in monkeys

Vaccination with the anthrax capsule--a naturally occurring component of the bacterium that causes the disease--completely protected monkeys from lethal anthrax infection, according to a study published online this week in the journal VACCINE.

27 Jun 2016

HDAC inhibitors may help regulate alcoholism-induced anxiety

Epigenetics is the study of changes in organisms caused by modifying gene expression - by alcohol, for example - rather than alteration of the genetic code itself. Recent evidence suggests that alcohol can inhibit activity of an enzyme called histone deacetylase (HDAC) in the amygdala, a brain region that is crucial for storing memories and regulating fear, anxiety, and other emotions.

27 Jun 2016

Pharmaceutical News

Inhalable ibuprofen holds potential to treat cystic fibrosis

New supplement could help reduce urge to consume high-calorie foods

Paracetamol use during pregnancy linked to hyperactivity, autism spectrum symptoms in children

Targeted molecular therapy reduces initial development of NAFLD in mice

Researchers test experimental Zika virus vaccine in mice

New study may help develop effective medication for severe pain

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

Allergy-causing immune cells play life-saving role in deadly C. difficile infection

Researcher receives federal grant to advance study of tumor nanoimmunology

Programs to prevent prescription drug misuse may be underused, study reveals

Tiny doses of anti-HIV drug may be effective for treating Alzheimer's disease

Bioengineers develop 2-in-1 nanomedicine for treating cancer

Experimental lipid-lowering drug improves glucose control in diabetic patients

Blocking c-Abl enzyme prevents Parkinson’s disease progression in mice

Researchers test new drug with potential to reverse or slow progression of asthma

Pain reliever appears to help preserve vision in animal model of retinal degeneration

Cisplatin-based chemotherapy may lead to hearing loss in many testicular cancer survivors

Anti-anxiety medication dampens helping behavior in rats

Anthrax capsule vaccine offers protection from deadly anthrax infection in monkeys

HDAC inhibitors may help regulate alcoholism-induced anxiety

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News